Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB,…

By M. Claudon, C. Dietrich, B. Choi, David O. Cosgrove, Masatoshi Kudo, C. Nolsøe, F. Piscaglia, Stephanie R. Wilson, R. G. Barr, M. Chammas and 16 more. Ultrasound in Medicine and Biology, 2013

819 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/03d8803842794b7ba15fe9e06319b195bae657d5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Kudo
2. Laurent Castéra
3. Asociacion Latinoamericana para el Estudio del Higado

In Hepatology

1. M. Kudo
2. Laurent Castéra
3. Asociacion Latinoamericana para el Estudio del Higado

Citations in the corpus

• The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) (2018, neutral): “CEUS is essential for lesion characterization [140, 151] and accurate liver staging [3, 137, 152].”
• WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. (2015, methodology): “Reports of cavitation-based bioeffects have been associated with diagnostic ultrasound imaging in the presence of contrast agents and tissues known to contain gaseous bodies (e.g., lung) using MI values greater than 0.4 (Miller et al., 2008)(Claudon et al., 2013).”
• Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. (2014, methodology): “While CT and MR imaging use have been traditionally described, contrast material–enhanced US is also now well established and commonly used in performing image guidance for all parts of an ablation procedure, and in many different organs (65).”